MARKSANSUpdated 1 Sept 2026, 12:21

Marksans Pharma Limited

MARKSANSUpdated 1 Sept 2026, 12:21

Market Cap

₹14,510Cr.

Current Price

₹320

High / Low

₹346/155

Stock P/E

45.1

ROE19.7%

ROCE25.6%

Book Value₹36.5

Face Value₹1.00

Dividend Yield0.28%

About

Marksans Pharma is engaged in the Business of Formulation of pharmaceutical products[1]

Quarterly results

Last reported quarters₹ Cr.

Annual statement₹ Cr.

As of Jun 2026%

Ownership over time%

Assets & liabilities₹ Cr.

Operating, investing & financing₹ Cr.

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	112	136	262	209	153	136	103	137	170	158	171	170
Inventory Days	85	90	95	91	109	111	101	100	121	145	117	102
Days Payable	75	64	67	73	58	84	69	72	103	122	116	97
Cash Conversion Cycle	123	161	290	228	204	163	135	165	188	182	172	174
Working Capital Days	29	91	177	149	127	144	90	110	143	144	145	150
ROCE %	33%	22%	3%	5%	12%	11%	23%	20%	14%	15%	19%	26%

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 1 September 2026 at 12:21